Table 2.
Abnormal findings in baseline FVS, in relation to anti‐inflammatory medication
| FVS (n = 80) | Continuous anti‐inflammatory medication (n = 18) | Intermittent anti‐inflammatory medication (n = 11) | No anti‐inflammatory medication (n = 51) | p* |
|---|---|---|---|---|
| FEV1 < 80% | 5 (28%) | 1 (9%) | 8 (16%) | 0.462 |
| FEV1/FVC < 88% | 4 (22%) | 4 (36%) | 5 (10%) | 0.058 |
| MEF50 < 62% | 4 (22%) | 2 (18%) | 7 (14%) | 0.605 |
| MEF25 < 48% | 5 (28%)† | 3 (27%) | 3 (6%) | 0.015 |
| At least one abnormal value | 7 (39%) | 4 (36%) | 15 (29%) | 0.729 |
*Fisher's exact test.
†p = 0.048 vs. no anti‐inflammatory medication (Fisher's exact test with Bonferroni correction).
Abbreviations are same as in Table 1.